(Q38004941)

26 August 2017

title

Opioid system and Alzheimer's disease (English)

1 reference

26 August 2017

0 references

0 references

Zhiyou Cai

1

1 reference

26 August 2017

Anna Ratka

series ordinal

2

1 reference

26 August 2017

publication date

22 April 2012

1 reference

26 August 2017

published in

NeuroMolecular Medicine

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

91-111

1 reference

Opioid receptors of human placental villi modulate acetylcholine release

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Kappa opioid receptors of human placental villi modulate acetylcholine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Structural modelling and mutation analysis of a nociceptin receptor and its ligand complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Modulation of opioid receptor function by protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neurodegeneration and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mu- and kappa-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid receptor density changes in Alzheimer amygdala and putamen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Deletion of mu-opioid receptor in mice alters the development of acute neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid peptides and receptors in joint tissues: study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe-OH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid growth factor modulates angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Processing of the synaptic cell adhesion molecule neurexin-3beta by Alzheimer disease alpha- and gamma-secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

kappa-Opioid receptor signaling and brain reward function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opiates, opioid peptides, and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid peptide inhibition of endogenous norepinephrine release from the A2 noradrenergic cell group in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Interactions between the effects of opioid, serotonin and alpha-2-adrenergic receptor agonists on growth hormone release in the male rat. Intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Vascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid receptors--the role of the sigma receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Central injection of a σ opioid receptor agonist alters body temperature of cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Binding of growth hormone-releasing hormones and enkephalin-derived growth hormone-releasing peptides to mu and delta opioid receptors in forebrain of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opiate receptor avidity and cerebral blood flow in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Imaging sigma receptors: applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Potential predictors of hippocampal atrophy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-endorphin and related peptides suppress phorbol myristate acetate-induced respiratory burst in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neurotransmitter receptors in the avian brain. III. GABA-benzodiazepine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Midregional Proenkephalin A and N-terminal Protachykinin A are decreased in the cerebrospinal fluid of patients with dementia disorders and acute neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Alzheimer's Disease: A General Introduction and Pathomechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

[125I][Tyr14]Orphanin binding to rat brain: evidence for labelling the opioid-receptor-like 1 (ORL1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Receptor imaging by PET and SPECT: focus on the opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Preservation of kappa 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid-induced hyperalgesia in a patient with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Application of “receptor theory provides further evidence for the existence of the ϵ-opioid receptor in rat vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mechanisms underlying inflammation in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Characterization of zebrafish proenkephalin reveals novel opioid sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alpha-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Glutamate transmission and toxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nicotine and endogenous opioids: Neurochemical and pharmacological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The endogenous opioid system and clinical pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Complete knockout of the nociceptin/orphanin FQ receptor in the rat does not induce compensatory changes in mu, delta and kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Effect of naltrexone on senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Hemorphin and hemorphin-like peptides isolated from dog pancreas and sheep brain are able to potentiate bradykinin activity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Amyloid-beta production in aged guinea pigs: atropine-induced enhancement is reversed by naloxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Exploring delta-receptor function using the selective opioid antagonist naltrindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Centrally mediated opioid induced depression of hepatic glutathione: effects of intracerebroventricular administration of mu, kappa, sigma and delta agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Enkephalins modulate excitatory synaptic transmission in the superficial dorsal horn by acting at mu-opioid receptor sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Quantitative distribution of the delta opioid receptor mRNA in the mouse and rat CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neurotransmitters in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid- and GABA(A)-receptors are co-expressed by neurons in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

In vitro studies of the activity of newly sinthesized nociceptin / orphanin FQ receptor ligand analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Synthesis and receptor binding properties of chimeric peptides containing a mu-opioid receptor ligand and nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-amide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Inactivity of phosphoethanolamine, an endogenous GABA analog decreased in Alzheimer's disease, at GABA binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

[3H][D-Pen2, D-Pen5]enkephalin binding to delta opioid receptors on intact neuroblastoma-glioma (NG 108-15) hybrid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Agonists and antagonists bind to different domains of the cloned kappa opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Changes in microtubular tau protein after morphine in a cultured human neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

kappa-1 Opioid receptors of the temporal cortex are preserved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Inhibition of luteinizing hormone-releasing hormone secretion by delta-opioid agonists in GT1-1 neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Morphine receptors in immunocytes and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Chemistry of mood and emotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

From the gate to the neuromatrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuromodulatory control of hippocampal function: towards a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The opioid peptides and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Molecular cloning and in situ hybridization histochemistry for rat mu-opioid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Immunohistochemical study of GABAA receptor alpha1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Tissue distribution of the opioid receptor-like (ORL1) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid-modulating peptides: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Respiratory function in adult mice lacking the mu-opioid receptor: role of delta-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuropeptides, behavior, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid peptides in the cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Amyloid precursor protein and BACE function as oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

GABA transporters (GAT-1) in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mechanisms of morphine-induced rewarding effect: involvement of NMDA receptor subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Role of delta-opioid receptor function in neurogenesis and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Alzheimer's disease pathogenesis and therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The function of the extracellular regions in opioid receptor binding: insights from computational biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Acetylcholine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-endorphin, somatostatin, and prolactin levels in cerebrospinal fluid of epileptic patients after generalised convulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

[11C]-MeJDTic: a novel radioligand for kappa-opioid receptor positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Quantification of hemorphins in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

CSF alpha-MSH in dementia of the Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Brain methionine- and leucine-enkephalin receptors in patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

GABA(A) receptors in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Decreased [3H]-naloxone binding and elevated dynorphin-A(1-8) content in Zucker rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

GABA--the quintessential neurotransmitter: electroneutrality, fidelity, specificity, and a model for the ligand binding site of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Tracking the evolution of the proenkephalin gene in tetrapods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Inhibition of BACE, a promising approach to Alzheimer's disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Role of mu-opioid receptor in immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nociceptin, OP4 receptor ligand in different models of experimental epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid neuronal denervation in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Abnormal opiate receptor functions in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Pouring oil into the fire? On the conundrum of the beneficial effects of NMDA receptor antagonists in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Etanercept Restores the Antinociceptive Effect of Morphine and Suppresses Spinal Neuroinflammation in Morphine-Tolerant Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

GABA function in mood disorders: an update and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Endogenous opioid regulation of norepinephrine release in guinea pig hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The molecular basis of opioid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opiate receptors and opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Regulation of male fertility by the opioid system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Role of nociceptin and opioid receptor like 1 on entrainment function in the rat suprachiasmatic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

CSF beta-endorphin and beta-lipotropin in Alzheimer's disease and multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Design and interpretation of opiate antagonist trials in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Physiologic and neuroendocrine responses to intravenous naloxone in subjects with Alzheimer's disease and age-matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor/mu-opioid receptor ligands: implications for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid modulation of GABA release in the rat inferior colliculus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The opioid receptor system and alcoholism: a genetic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Ultra-low-dose naloxone restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in PTX-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Evidence for epsilon-opioid receptor-mediated beta-endorphin-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Identification of potential GABA-mimetics by their actions on brain GABA recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Enhanced antidepressant efficacy of sigma1 receptor agonists in rats after chronic intracerebroventricular infusion of beta-amyloid-(1-40) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The cholinergic system, sigma-1 receptors and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-secretase (BACE) as a drug target for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

How opioids inhibit GABA-mediated neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Beta-secretase: structure, function, and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The JNK pathway amplifies and drives subcellular changes in tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Glutamate-glutamine cycling in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Mu-opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid receptor regulation of the release of norepinephrine in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Selective opioid antagonist effects on opioid-induced inhibition of release of norepinephrine in guinea pig cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Dysregulation of dynorphins in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

T lymphocyte proliferation is suppressed by the opioid growth factor ([Met5]-enkephalin)–opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Zeta (zeta), the opioid growth factor receptor: identification and characterization of binding subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The biology of the opioid growth factor receptor (OGFr)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Receptor reserve and affinity of mu opioid agonists in mouse antinociception: correlation with receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Attenuation of nociceptin/orphanin FQ-induced signaling by N-methyl-D-aspartate in neuronal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Functional Selectivity of Nociceptin/Orphanin FQ Peptide Receptor Partial Agonists on Cardiovascular and Renal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8180-3

Amyloid beta amyloidosis in Alzheimerʼs disease

21 January 2018

1 reference

12 December 2020

Comparison of behavioural effects of NocII or NocIII, two related pronociceptin-derived peptides

1 reference

12 December 2020

The effect of nociceptin, an endogenous ligand for the ORL1 receptor, on rat colonic contraction and transit

1 reference

12 December 2020

Cerebrospinal fluid levels of leucine enkephalin and methionine enkephalin in patients with altered behavior

1 reference

12 December 2020

Neurofibrillary tangles and tau phosphorylation.

1 reference

12 December 2020

[Opioid peptides: metabolism and receptors]

1 reference

12 December 2020

Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.

1 reference

12 December 2020

Regulatory role of enteric mu and kappa opioid receptors in the release of acetylcholine and norepinephrine from guinea pig ileum

1 reference

12 December 2020

1 reference

12 December 2020

Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex

1 reference

12 December 2020

Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease

1 reference

12 December 2020

Cycloheximide increases proenkephalin and tyrosine hydroxylase gene expression in rat adrenal medulla

1 reference

12 December 2020

Protease pathways in peptide neurotransmission and neurodegenerative diseases

1 reference

12 December 2020

Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists

1 reference

12 December 2020

The influence of neuropeptides related to pro-opiomelanocortin on acquisition of heroin self-administration of rats

1 reference

12 December 2020

Conformation-activity relationships of opioid peptides with selective activities at opioid receptors

1 reference

12 December 2020

Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies.

1 reference

12 December 2020

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type

1 reference

12 December 2020

Identification and characterization of the zeta-opioid receptor in developing rat heart

1 reference

12 December 2020

Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization.

1 reference

12 December 2020

Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor

1 reference

12 December 2020

Effect of mu, delta and kappa opioid receptor agonists on a reactive oxygen species mediated model of skin inflammation

1 reference

12 December 2020

Opioid Peptides and their Receptors

1 reference

12 December 2020

Steroid binding at sigma receptors: CNS and immunological implications.

1 reference

12 December 2020

Dynorphin and enkephalins in adrenal paraneurones. Opiates in the adrenal medulla

1 reference

12 December 2020

The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat

1 reference

12 December 2020

Sigma-1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa-opioid receptor agonist U-50488H.

1 reference

12 December 2020

Abnormal pro-opiomelanocortin processing in Alzheimer's disease. A case report

1 reference

12 December 2020

Opioid modulation of recurrent excitation in the hippocampal dentate gyrus.

1 reference

12 December 2020

Light microscopic autoradiographic localization of delta opioid receptors in the rat brain using a highly selective bis-penicillamine cyclic enkephalin analog

1 reference

12 December 2020

Anti-opioid action of glutamate-NMDA receptor systems underlying morphine analgesic tolerance

1 reference

12 December 2020

Leads to current therapy, to opioid receptor subtypes and to sigma receptors

1 reference

12 December 2020

Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue

1 reference

12 December 2020

Pharmacological modification of glutamate neurotoxicity in vivo

1 reference

12 December 2020

Do we undervalue feelings in patients who are cognitively impaired?

1 reference

12 December 2020

N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.

1 reference

12 December 2020

Neuroprotective effect of naloxone in inflammation-mediated dopaminergic neurodegeneration. Dissociation from the involvement of opioid receptors

1 reference

12 December 2020

Identification and characterization of zeta-opioid receptor in human colon cancer

1 reference

12 December 2020

GABA-agonist therapy for Alzheimer's disease

1 reference

12 December 2020

Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.

1 reference

12 December 2020

[Neuropeptides in Alzheimer's disease]

1 reference

12 December 2020

Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use.

1 reference

12 December 2020

Effects of prior exposure to morphine on the opioid inhibition of the stimulated release of [3H]norepinephrine from guinea pig cortex slices.

1 reference

12 December 2020

[Drug dependent adolescents have Alzheimer disease-like brains].

1 reference

12 December 2020

Opioid effects on [3H]norepinephrine release from dissociated embryonic locus coeruleus cell cultures.

1 reference

12 December 2020

[Apoptosis and Alzheimer disease. Contribution of cellular and transgenic models]

1 reference

12 December 2020

[Glutamate and Alzheimer's disease]

1 reference

12 December 2020

Opioid peptides, opioid receptors and mechanism of down regulation.

1 reference

12 December 2020

1 reference

12 December 2020

Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion.

1 reference

12 December 2020

History of opium poppy and morphine

1 reference

12 December 2020

Enkephalins modulate differentiation of normal human keratinocytes in vitro

1 reference

12 December 2020

[Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse]

1 reference

12 December 2020

Iron, neuroinflammation, and Alzheimer's disease

1 reference

12 December 2020

[Monoclonal antibodies to alpha-endorphin effective in immunohistochemistry and immunoblotting]

1 reference

12 December 2020

No evidence for involvement of endogenous opioid peptides in effects of clonidine on blood pressure, heart rate and plasma norepinephrine in anesthetized rats.

1 reference

12 December 2020

Loss of cortical GABA uptake sites in Alzheimer's disease

1 reference

12 December 2020

Serotonin dysfunction disorders: a behavioral neurochemistry perspective.

1 reference

12 December 2020

Limbic regions of the brain of Alzheimer's disease patients show selective changes in mu, delta and kappa opioid receptor binding

1 reference

12 December 2020

Alzheimer's disease, oxidative injury, and cytokines.

1 reference

12 December 2020

[Cloning of prepronociceptin has led to the discovery of other biologically active peptides].

1 reference

12 December 2020

Opioid receptor-mediated control of acetylcholine release in human neocortex tissue

1 reference

12 December 2020

Molecular regulation of opioid receptors

1 reference

12 December 2020

Alcohol use in adolescents with eating disorders

1 reference

12 December 2020

Major difference in the expression of delta- and mu-opioid receptors between turtle and rat brain

1 reference

12 December 2020

Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies.

1 reference

12 December 2020

Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection.

1 reference

12 December 2020

Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA.

1 reference

12 December 2020

Autoradiographic localization of [3H]nociceptin binding sites in the rat brain

1 reference

12 December 2020

Hemorphin peptides are released from hemoglobin by cathepsin D. radioimmunoassay against the C-part of V-V-hemorphin-7: an alternative assay for the cathepsin D activity

1 reference

12 December 2020

Neural activation of opioid mechanisms in guinea pig ileum by excitatory peptides

1 reference

12 December 2020

Gamma-aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues

1 reference

12 December 2020

Role of the beta-amyloid protein in Alzheimer's disease.

1 reference

12 December 2020

Endorphins, opioid receptors and site of action of morphinomimetics

1 reference

12 December 2020

Brain receptor imaging

1 reference

12 December 2020

Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor

1 reference

12 December 2020

Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.

1 reference

12 December 2020

Release of hemorphin-5 from human hemoglobin by pancreatic elastase

1 reference

12 December 2020

The amyloid precursor protein fragment His 657-Lys 676 inhibits noradrenaline- and enkephaline-induced suppression of voltage sensitive calcium currents in NG108-15 hybrid cells

1 reference

12 December 2020

Synaptically released neurotransmitter fails to desensitize postsynaptic GABA(A) receptors in cerebellar cultures

1 reference

12 December 2020

Synthesis and central none-opioid analgesic activity of SIPI5047

1 reference

12 December 2020

Alzheimer-associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells.

1 reference

12 December 2020

10.1007/S12017-012-8180-3

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1020510606

0 references

1 reference